“…Several network-based methodologies also provide efficient tools to establish associations between drugs and diseases via assembling disease genes and drug-target interactions (DTIs) in human protein–protein interactome. For instance, our previous studies have demonstrated that network-based infrastructure is of great value for prioritizing potential drug candidates toward numerous diseases, such as SARS-CoV-2 [13] and Alzheimer’s disease [14] , [15] .…”